The role of Na/K-ATPase signaling in oxidative stress related to obesity and cardiovascular disease

Molecules

Volumn 21, Issue 9, 2016, Pages

  Srikanthan, Krithika ^a   Shapiro, Joseph I ^a   Sodhi, Komal ^a  

^a MARSHALL UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiovascular disease; Na K ATPase; Obesity; Oxidative stress; PNaKtide

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); REACTIVE OXYGEN METABOLITE;

ANIMAL; CARDIOVASCULAR DISEASE; HUMAN; METABOLISM; OBESITY; OXIDATIVE STRESS; SIGNAL TRANSDUCTION;

ANIMALS; CARDIOVASCULAR DISEASES; HUMANS; OBESITY; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; SODIUM-POTASSIUM-EXCHANGING ATPASE;

EID: 84987923397     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules21091172     Document Type: Review

References (74)

1. Yan, Y.; Shapiro, J.I. The physiological and clinical importance of sodium potassium ATPase in cardiovascular diseases. Curr. Opin. Pharmacol. 2016, 27, 43-49.
2. Li, Z.; Zhang, Z.; Xie, J.X.; Li, X.; Tian, J.; Cai, T.; Cui, H.; Ding, H.; Shapiro, J.I.; Xie, Z. Na/K-ATPase mimetic pNaKtide peptide inhibits the growth of human cancer cells. J. Biol. Chem. 2011, 286, 32394-32403.
3. Sodhi, K.; Maxwell, K.; Yan, Y.; Liu, J.; Chaudhry, M.A.; Getty, M.; Xie, Z.; Abraham, N.G.; Shapiro, J.I. pNaKtide inhibits Na/K-ATPase reactive oxygen species amplification and attenuates adipogenesis. Sci. Adv. 2015, 1, e1500781.
4. Tian, J.; Cai, T.; Yuan, Z.; Wang, H.; Liu, L.; Haas, M.; Maksimova, E.; Huang, X.Y.; Xie, Z.J. Binding of Src to Na+/K+-ATPase forms a functional signaling complex. Mol. Biol. Cell 2006, 17, 317-326.
5. Wang, H.; Haas, M.; Liang, M.; Cai, T.; Tian, J.; Li, S.; Xie, Z. Ouabain assembles signaling cascades through the caveolar Na+ /K+ -ATPase. J. Biol. Chem. 2004, 279, 17250-17259.
6. Kotova, O.; Al-Khalili, L.; Talia, S.; Hooke, C.; Fedorova, O.V.; Bagrov, A.Y.; Chibalin, A.V. Cardiotonic steroids stimulate glycogen synthesis in human skeletal muscle cells via a Src- and ERK1/2-dependent mechanism. J. Biol. Chem. 2006, 281, 20085-20094.
7. Liang, M.; Cai, T.; Tian, J.; Qu, W.; Xie, Z.J. Functional characterization of Src-interacting Na/K-ATPase using RNA interference assay. J. Biol. Chem. 2006, 281, 19709-19719.
8. Liu, L.; Mohammadi, K.; Aynafshar, B.; Wang, H.; Li, D.; Liu, J.; Ivanov, A.V.; Xie, Z.; Askari, A. Role of caveolae in signal-transducing function of cardiac Na+ /K+ -ATPase. Am. J. Physiol. Cell Physiol. 2003, 284, C1550-C1560.
9. Gable, M.E.; Abdallah, S.L.; Najjar, S.M.; Liu, L.; Askari, A. Digitalis-induced cell signaling by the sodium pump: On the relation of Src to Na(+)/K(+)-ATPase. Biochem. Biophys. Res. Commun. 2014, 446, 1151-1154.
10. Ye, Q.Q.; Li, Z.C.; Tian, J.; Xie, J.X.; Liu, L.J.; Xie, Z.J. Identification of a potential receptor that couples ion transport to protein kinase activity. J. Biol. Chem. 2011, 286, 6225-6232.
11. Liu, L.; Ivanov, A.V.; Gable, M.E.; Jolivel, F.; Morrill, G.A.; Askari, A. Comparative properties of caveolar and noncaveolar preparations of kidney Na+ /K+ -ATPase. Biochemistry 2011, 50, 8664-8673.
12. Weigand, K.M.; Swarts, H.G.; Fedosova, N.U.; Russel, F.G.; Koenderink, J.B. Na,K-ATPase activity modulates Src activation: A role for ATP/ADP ratio. Biochim. Biophys. Acta 2012, 1818, 1269-1273.
13. Yosef, E.; Katz, A.; Peleg, Y.; Mehlman, T.; Karlish, S.J. Do Src Kinase and Caveolin Interact Directly with Na,K-ATPase? J. Biol. Chem. 2016, 291, 11736-11750.
14. Clifford, R.J.; Kaplan, J.H. Human breast tumor cells are more resistant to cardiac glycoside toxicity than non-tumorigenic breast cells. PLoS ONE 2013, 8, e84306.
15. Li, Z.; Xie, Z. The Na/K-ATPase/Src complex and cardiotonic steroid-activated protein kinase cascades. Pflugers Arch. 2009, 457, 635-644.
16. Liu, J.; Kennedy, D.J.; Yan, Y.; Shapiro, J.I. Reactive Oxygen Species Modulation of Na/K-ATPase Regulates Fibrosis and Renal Proximal Tubular Sodium Handling. Int. J. Nephrol. 2012, 2012.
17. Kim, M.S.; Akera, T. O2 free radicals: Cause of ischemia-reperfusion injury to cardiac Na+ -K+ -ATPase. Am. J. Physiol. 1987, 252, H252-H257.
18. Xie, Z.J.; Wang, Y.H.; Askari, A.; Huang, W.H.; Klaunig, J.E.; Askari, A. Studies on the specificity of the effects of oxygen metabolites on cardiac sodium pump. J. Mol. Cell Cardiol. 1990, 22, 911-920.
19. Huang, W.H.; Wang, Y.; Askari, A. (Na+ + K+ )-ATPase: Inactivation and degradation induced by oxygen radicals. Int. J. Biochem. 1992, 24, 621-626.
20. Huang, W.H.; Wang, Y.; Askari, A.; Zolotarjova, N.; Ganjeizadeh, M. Different sensitivities of the Na+/K(+)-ATPase isoforms to oxidants. Biochim. Biophys. Acta 1994, 1190, 108-114.
21. Xie, Z.; Jack-Hays, M.; Wang, Y.; Periyasamy, S.M.; Blanco, G.; Huang, W.H.; Askari, A. Different oxidant sensitivities of the alpha 1 and alpha 2 isoforms of Na+/K(+)-ATPase expressed in baculovirus-infected insect cells. Biochem. Biophys. Res. Commun. 1995, 207, 155-159.
22. Zolotarjova, N.; Ho, C.; Mellgren, R.L.; Askari, A.; Huang, W.H. Different sensitivities of native and oxidized forms of Na+/K(+)-ATPase to intracellular proteinases. Biochim. Biophys. Acta 1994, 1192, 125-131.
23. Thevenod, F.; Friedmann, J.M. Cadmium-mediated oxidative stress in kidney proximal tubule cells induces degradation of Na+/K(+)-ATPase through proteasomal and endo-/lysosomal proteolytic pathways. FASEB J. 1999, 13, 1751-1761.
24. Figtree, G.A.; Liu, C.C.; Bibert, S.; Hamilton, E.J.; Garcia, A.; White, C.N.; Chia, K.K.; Cornelius, F.; Geering, K.; Rasmussen, H.H. Reversible oxidative modification: A key mechanism of Na+-K+ pump regulation. Circ. Res. 2009, 105, 185-193.
25. Bibert, S.; Liu, C.C.; Figtree, G.A.; Garcia, A.; Hamilton, E.J.; Marassi, F.M.; Sweadner, K.J.; Cornelius, F.; Geering, K.; Rasmussen, H.H. FXYD proteins reverse inhibition of the Na+-K+ pump mediated by glutathionylation of its beta1 subunit. J. Biol. Chem. 2011, 286, 18562-18572.
26. Petrushanko, I.Y.; Yakushev, S.; Mitkevich, V.A.; Kamanina, Y.V.; Ziganshin, R.H.; Meng, X.; Anashkina, A.A.; Makhro, A.; Lopina, O.D.; Gassmann, M.; et al. S-glutathionylation of the Na,K-ATPase catalytic alpha subunit is a determinant of the enzyme redox sensitivity. J. Biol. Chem. 2012, 287, 32195-32205.
27. Wong, C.M.; Cheema, A.K.; Zhang, L.; Suzuki, Y.J. Protein carbonylation as a novel mechanism in redox signaling. Circ. Res. 2008, 102, 310-318.
28. Yan, Y.; Shapiro, A.P.; Haller, S.; Katragadda, V.; Liu, L.; Tian, J.; Basrur, V.; Malhotra, D.; Xie, Z.J.; Abraham, N.G.; et al. Involvement of reactive oxygen species in a feed-forward mechanism of Na/K-ATPase-mediated signaling transduction. J. Biol. Chem. 2013, 288, 34249-34258.
29. Cheung, J.Y.; Rothblum, L.I.; Moorman, J.R.; Tucker, A.L.; Song, J.; Ahlers, B.A.; Carl, L.L.; Wang, J.; Zhang, X.Q. Regulation of cardiac Na+ /Ca2+ exchanger by phospholemman. Ann. N. Y. Acad. Sci. 2007, 1099, 119-134.
30. Bogdanova, A.; Petrushanko, I.Y.; Hernansanz-Agustin, P.; Martinez-Ruiz, A. "Oxygen Sensing" by Na,K-ATPase: These Miraculous Thiols. Front. Physiol. 2016, 7, 314.
31. Siems, W.G.; Hapner, S.J.; van Kuijk, F.J. 4-hydroxynonenal inhibits Na(+)-K(+)-ATPase. Free Radic. Biol. Med. 1996, 20, 215-223.
32. Morel, P.; Tallineau, C.; Pontcharraud, R.; Piriou, A.; Huguet, F. Effects of 4-hydroxynonenal, a lipid peroxidation product, on dopamine transport and Na+ /K+ ATPase in rat striatal synaptosomes. Neurochem. Int. 1998, 33, 531-540.
33. Yamaguchi, T.; Nagashima, R.; Yoneyama, M.; Shiba, T.; Ogita, K. Disruption of ion-trafficking system in the cochlear spiral ligament prior to permanent hearing loss induced by exposure to intense noise: Possible involvement of 4-hydroxy-2-nonenal as a mediator of oxidative stress. PLoS ONE 2014, 9, e102133.
34. Li, Z.; Cai, T.; Tian, J.; Xie, J.X.; Zhao, X.; Liu, J. L.; Shapiro, I.; Xie, Z. NaKtide, a Na/K-ATPase-derived peptide Src inhibitor, antagonizes ouabain-activated signal transduction in cultured cells. J. Biol. Chem. 2009, 284, 21066-21076.
35. Kraker, A.J.; Hartl, B.G.; Amar, A.M.; Barvian, M.R.; Showalter, H.D.; Moore, C.W. Biochemical and cellular effects of c-Src kinase-selective pyrido[2, 3-d]pyrimidine tyrosine kinase inhibitors. Biochem. Pharmacol. 2000, 60, 885-898.
36. Abe, J.; Takahashi, M.; Ishida, M.; Lee, J.D.; Berk, B.C. c-Src is required for oxidative stress-mediated activation of big mitogen-activated protein kinase 1. J. Biol. Chem. 1997, 272, 20389-20394.
37. Burkard, C.; Verheije, M.H.; Haagmans, B.L.; van Kuppeveld, F.J.; Rottier, P.J.; Bosch, B.J.; de Haan, C.A. ATP1A1-mediated Src signaling inhibits coronavirus entry into host cells. J. Virol. 2015, 89, 4434-4448.
38. De Pauw, A.; Tejerina, S.; Raes, M.; Keijer, J.; Arnould, T. Mitochondrial (dys)function in adipocyte (de)differentiation and systemic metabolic alterations. Am. J. Pathol. 2009, 175, 927-939.
39. Burgess, A.; Li, M.; Vanella, L.; Kim, D.H.; Rezzani, R.; Rodella, L.; Sodhi, K.; Canestraro, M.; Martasek, P.; Peterson, S.J.; et al. Adipocyte heme oxygenase-1 induction attenuates metabolic syndrome in both male and female obese mice. Hypertension 2010, 56, 1124-1130.
40. Li, M.; Kim, D.H.; Tsenovoy, P.L.; Peterson, S.J.; Rezzani, R.; Rodella, L.F.; Aronow, W.S.; Ikehara, S.; Abraham, N.G. Treatment of obese diabetic mice with a heme oxygenase inducer reduces visceral and subcutaneous adiposity, increases adiponectin levels, and improves insulin sensitivity and glucose tolerance. Diabetes 2008, 57, 1526-1535.
41. Lafontan, M. Adipose tissue and adipocyte dysregulation. Diabetes Metab. 2014, 40, 16-28.
42. Crujeiras, A.B.; Diaz-Lagares, A.; Carreira, M.C.; Amil, M.; Casanueva, F.F. Oxidative stress associated to dysfunctional adipose tissue: A potential link between obesity, type 2 diabetes mellitus and breast cancer. Free Radic. Res. 2013, 47, 243-256.
43. Furukawa, S.; Fujita, T.; Shimabukuro, M.; Iwaki, M.; Yamada, Y.; Nakajima, Y.; Nakayama, O.; Makishima, M.; Matsuda, M.; Shimomura, I. Increased oxidative stress in obesity and its impact on metabolic syndrome. J. Clin. Investig. 2004, 114, 1752-1761.
44. Urakawa, H.; Katsuki, A.; Sumida, Y.; Gabazza, E.C.; Murashima, S.; Morioka, K.; Maruyama, N.; Kitagawa, N.; Tanaka, T.; Hori, Y.; et al. Oxidative stress is associated with adiposity and insulin resistance in men. J. Clin. Endocrinol. Metab. 2003, 88, 4673-4676.
45. Vincent, H.K.; Taylor, A.G. Biomarkers and potential mechanisms of obesity-induced oxidant stress in humans. Int. J. Obes. (Lond.) 2006, 30, 400-418.
46. Le Lay, S.; Simard, G.; Martinez, M.C.; Andriantsitohaina, R. Oxidative stress and metabolic pathologies: From an adipocentric point of view. Oxid. Med. Cell. Longev. 2014, 2014.
47. Talior, I.; Yarkoni, M.; Bashan, N.; Eldar-Finkelman, H. Increased glucose uptake promotes oxidative stress and PKC-delta activation in adipocytes of obese, insulin-resistant mice. Am. J. Physiol. Endocrinol. Metab. 2003, 285, E295-E302.
48. Mozaffarian, D.; Benjamin, E.J.; Go, A.S.; Arnett, D.K.; Blaha, M.J.; Cushman, M.; Das, S.R.; de Ferranti, S.; Despres, J.P.; Fullerton, H.J.; et al. Executive Summary: Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation 2016, 133, 447-454.
49. Wilson-Fritch, L.; Nicoloro, S.; Chouinard, M.; Lazar, M.A.; Chui, P.C.; Leszyk, J.; Straubhaar, J.; Czech, M.P.; Corvera, S. Mitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone. J. Clin. Invest. 2004, 114, 1281-1289.
50. Xu, H.; Barnes, G.T.; Yang, Q.; Tan, G.; Yang, D.; Chou, C.J.; Sole, J.; Nichols, A.; Ross, J.S.; Tartaglia, L.A.; et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Investig. 2003, 112, 1821-1830.
51. Weisberg, S.P.; McCann, D.; Desai, M.; Rosenbaum, M.; Leibel, R.L.; Ferrante, A.W., Jr. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Investig. 2003, 112, 1796-1808.
52. De Marchi, E.; Baldassari, F.; Bononi, A.; Wieckowski, M.R.; Pinton, P. Oxidative stress in cardiovascular diseases and obesity: Role of p66Shc and protein kinase C. Oxid. Med. Cell. Longev. 2013, 2013.
53. Srikanthan, K.; Feyh, A.; Visweshwar, H.; Shapiro, J.I.; Sodhi, K. Systematic Review of Metabolic Syndrome Biomarkers: A Panel for Early Detection, Management, and Risk Stratification in the West Virginian Population. Int. J. Med. Sci. 2016, 13, 25-38.
54. Lakshmi, S.V.; Padmaja, G.; Kuppusamy, P.; Kutala, V.K. Oxidative stress in cardiovascular disease. Indian J. Biochem. Biophys. 2009, 46, 421-40.
55. Fruchart, J.C.; Nierman, M.C.; Stroes, E.S.; Kastelein, J.J.; Duriez, P. New risk factors for atherosclerosis and patient risk assessment. Circulation 2004, 109.
56. Bonomini, F.; Tengattini, S.; Fabiano, A.; Bianchi, R.; Rezzani, R. Atherosclerosis and oxidative stress. Histol. Histopathol. 2008, 23, 381-390.
57. Harrison, D.; Griendling, K.K.; Landmesser, U.; Hornig, B.; Drexler, H. Role of oxidative stress in atherosclerosis. Am. J. Cardiol. 2003, 91, 7A-11A.
58. Vogiatzi, G.; Tousoulis, D.; Stefanadis, C. The role of oxidative stress in atherosclerosis. Hellenic J. Cardiol. 2009, 50, 402-409.
59. Saavedra, W.F.; Paolocci, N.; St John, M.E.; Skaf, M.W.; Stewart, G.C.; Xie, J.S.; Harrison, R.W.; Zeichner, J.; Mudrick, D.; Marban, E.; et al. Imbalance between xanthine oxidase and nitric oxide synthase signaling pathways underlies mechanoenergetic uncoupling in the failing heart. Circ. Res. 2002, 90, 297-304.
60. De Biase, L.; Pignatelli, P.; Lenti, L.; Tocci, G.; Piccioni, F.; Riondino, S.; Pulcinelli, F.M.; Rubattu, S.; Volpe, M.; Violi, F. Enhanced TNF alpha and oxidative stress in patients with heart failure: Effect of TNF alpha on platelet O2 -production. Thromb. Haemost. 2003, 90, 317-325.
61. Kuroda, J.; Ago, T.; Matsushima, S.; Zhai, P.; Schneider, M.D.; Sadoshima, J. NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart. Proc. Natl. Acad. Sci. USA 2010, 107, 15565-15570.
62. Schwinger, R.H.; Bundgaard, H.; Muller-Ehmsen, J.; Kjeldsen, K. The Na, K-ATPase in the failing human heart. Cardiovasc. Res. 2003, 57, 913-920.
63. Kennedy, D.; Omran, E.; Periyasamy, S.M.; Nadoor, J.; Priyadarshi, A.; Willey, J.C.; Malhotra, D.; Xie, Z.; Shapiro, J.I. Effect of chronic renal failure on cardiac contractile function, calcium cycling, and gene expression of proteins important for calcium homeostasis in the rat. J. Am. Soc. Nephrol. 2003, 14, 90-97.
64. Kennedy, D.J.; Vetteth, S.; Xie, M.; Periyasamy, S.M.; Xie, Z.; Han, C.; Basrur, V.; Mutgi, K.; Fedorov, V.; Malhotra, D.; et al. Ouabain decreases sarco(endo)plasmic reticulum calcium ATPase activity in rat hearts by a process involving protein oxidation. Am. J. Physiol. Heart Circ. Physiol. 2006, 291, H3003-H3011.
65. Himmelfarb, J.; Stenvinkel, P.; Ikizler, T.A.; Hakim, R.M. The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int. 2002, 62, 1524-1538.
66. Tian, J.; Shidyak, A.; Periyasamy, S.M.; Haller, S.; Taleb, M.; El-Okdi, N.; Elkareh, J.; Gupta, S.; Gohara, S.; Fedorova, O.V.; et al. Spironolactone attenuates experimental uremic cardiomyopathy by antagonizing marinobufagenin. Hypertension 2009, 54, 1313-1320.
67. Kennedy, D.J.; Elkareh, J.; Shidyak, A.; Shapiro, A.P.; Smaili, S.; Mutgi, K.; Gupta, S.; Tian, J.; Morgan, E.; Khouri, S.; et al. Partial nephrectomy as a model for uremic cardiomyopathy in the mouse. Am. J. Physiol. Renal Physiol. 2008, 294, F450-F454.
68. Kennedy, D.J.; Vetteth, S.; Periyasamy, S.M.; Kanj, M.; Fedorova, L.; Khouri, S.; Kahaleh, M.B.; Xie, Z.; Malhotra, D.; Kolodkin, N.I. Central role for the cardiotonic steroid marinobufagenin in the pathogenesis of experimental uremic cardiomyopathy. Hypertension 2006, 47, 488-495.
69. Haller, S.T.; Kennedy, D.J.; Shidyak, A.; Budny, G.V.; Malhotra, D.; Fedorova, O.V.; Shapiro, J.I.; Bagrov, A.Y. Monoclonal antibody against marinobufagenin reverses cardiac fibrosis in rats with chronic renal failure. Am. J. Hypertens 2012, 25, 690-696.
70. Touyz, R.M.; Briones, A.M. Reactive oxygen species and vascular biology: Implications in human hypertension. Hypertens Res. 2011, 34, 5-14.
71. Garvin, J.L.; Ortiz, P.A. The role of reactive oxygen species in the regulation of tubular function. Acta Physiol. Scand. 2003, 179, 225-232.
72. Schiffrin, E.L.; Touyz, R.M. Multiple actions of angiotensin II in hypertension: Benefits of AT1 receptor blockade. J. Am. Coll. Cardiol. 2003, 42, 911-913.
73. Gill, P.S.; Wilcox, C.S. NADPH oxidases in the kidney. Antioxid. Redox. Signal. 2006, 8, 1597-1607.
74. Wilcox, C.S. Oxidative stress and nitric oxide deficiency in the kidney: A Critical link to hypertension? Am. J. Physiol. Regul. Integr. Comp. Physiol. 2005, 289, R913-R935.